Wednesday, 25 November 2020

BCLI Flunks Phase II ALS Study, LXRX Aces Sotagliflozin Trials, KZIA On Watch, FDA Snubs ALKS

Today’s Daily Dose brings you news about FDA’s refusal to approve Alkermes’ antipsychotic drug ALKS 3831, BrainStorm’s NurOwn failing in amyotrophic lateral sclerosis study, Lexicon Pharma’s Sotagliflozin acing phase III trials and Kazia’s updated data of Paxalisib in glioblastoma. Read on… 1. FDA Says “No” To Alkermes’ Antipsychotic Drug ALKS…

Biden's streak of receiving softball questions from journalists continues

Biden fielding softball questions Reporters invite him to attack Trump Joe Biden managed to coast through the 2020 election campaign without facing a serious grilling from the press, but even now and as the president-elect, his streak of receiving softball questions from reporters continues.  Speaking briefly to reporters on Tuesday in…

Latino, Black leaders demand Newsom choose woman of color for Senate seat

Fox News Flash top headlines for Nov. 24 Fox News Flash top headlines are here. Check out what’s clicking on FoxNews.com. California progressives are hoping to influence Gov. Gavin Newsom's pick for someone to fill Kamala Harris’ Senate seat when she becomes vice president in January. In 2016, Harris became only the…